Bone marrow mesenchymal stem cells attenuate lung inflammation of hyperoxic newborn rats

Pediatric Transplantation

Volumn 16, Issue 6, 2012, Pages 589-598

  Zhang, Hongshan ^a   Fang, Jianpei ^a   Su, Haobin ^a   Yang, Min ^b   Lai, Wenyu ^a   Mai, Yougang ^a   Wu, Yanyun ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

bronchopulmonary dysplasia; inflammation; lung; mesenchymal stem cells; oxygen

Indexed keywords

BETA1 INTEGRIN; GREEN FLUORESCENT PROTEIN; HERMES ANTIGEN; LENTIVIRUS VECTOR; OXYGEN; THY 1 ANTIGEN;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CARTILAGE CELL; CELL DIFFERENTIATION; CELL ISOLATION; CONTROLLED STUDY; GENE EXPRESSION; HISTOLOGY; HYPEROXIA; IN VITRO GENE TRANSFER; LUNG DYSPLASIA; MESENCHYMAL STEM CELL; NEWBORN; NONHUMAN; OSTEOBLAST; PNEUMONIA; RANDOMIZED CONTROLLED TRIAL; RAT; TISSUE LEVEL; WEIGHT GAIN;

ADIPOCYTES; ANIMALS; ANIMALS, NEWBORN; ANTIGENS, CD29; ANTIGENS, CD44; ANTIGENS, THY-1; BONE MARROW CELLS; BRONCHOPULMONARY DYSPLASIA; CELL DIFFERENTIATION; CHONDROCYTES; DISEASE MODELS, ANIMAL; GREEN FLUORESCENT PROTEINS; HUMANS; HYPEROXIA; INFANT, NEWBORN; INFLAMMATION; LENTIVIRUS; MESENCHYMAL STROMAL CELLS; OSTEOBLASTS; OXYGEN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84864583293     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2012.01709.x     Document Type: Article

References (44)

1. De Kleine MJ, Den Ouden AL, Kollée LA, et al., Lower mortality but higher neonatal morbidity over a decade in very preterm infants. Paediatr Perinat Epidemiol 2007: 21: 15-25. (Pubitemid 46103038)
2. Christou H, Brodsky D,. Lung injury and bronchopulmonary dysplasia in newborn infants. J Intensive Care Med 2005: 20: 76-87. (Pubitemid 43093899)
3. Ahola T, Lapatto R, Raivio KO, et al., N-acetylcysteine does not prevent bronchopulmonary dysplasia in immature infants: A randomized controlled trial. J Pediatr 2003: 143: 713-719. (Pubitemid 37510637)
4. Schreiber MD, Gin-Mestan K, Marks JD, Huo D, Lee G, Srisuparp P,. Inhaled nitric oxide in premature infants with the respiratory distress syndrome. N Engl J Med 2003: 349: 2099-2107. (Pubitemid 37464534)
5. Jeng SF, Hsu CH, Tsao PN, et al., Bronchopulmonary dysplasia predicts adverse developmental and clinical outcomes in very-lowbirthweight infants. Dev Med Child Neurol 2008: 50: 51-57.
6. Saigal S, Doyle LW,. An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet 2008: 371: 261-269.
7. Rojas M, Xu J, Woods CR, et al., Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 2005: 33: 145-152. (Pubitemid 41473051)
8. Ortiz LA, Gambelli F, McBride C, et al., Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci U S A 2003: 100: 8407-8411. (Pubitemid 36842558)
9. Spees JL, Whitney MJ, Sullivan DE, et al., Bone marrow progenitor cells contribute to repair and remodeling of the lung and heart in a rat model of progressive pulmonary hypertension. FASEB J 2008: 22: 1226-1236. (Pubitemid 351519976)
10. Mei SH, McCarter SD, Deng Y, Parker CH, Liles WC, Stewart DJ,. Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1. PLoS Med 2007: 4: e269.
11. Xu J, Woods CR, Mora AL, et al., Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice. Am J Physiol Lung Cell Mol Physiol 2007: 293: L131-L141. (Pubitemid 47080721)
12. Gupta N, Su X, Popov B, Lee JW, Serikov V, Matthay MA,. Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol 2007: 179: 1855-1863.
13. Lee JW, Gupta N, Serikov V, Matthay MA,. Potential application of mesenchymal stem cells in acute lung injury. Expert Opin Biol Ther 2009: 9: 1259-1270.
14. Suratt BT, Cool CD, Serls AE, et al., Human pulmonary chimerism after hematopoietic stem cell transplantation. Am J Respir Crit Care Med 2003: 168: 318-322. (Pubitemid 36969883)
15. Albera C, Polak JM, Janes S, et al., Repopulation of human pulmonary epithelium by bone marrow cells: A potential means to promote repair. Tissue Eng 2005: 11: 1115-1121. (Pubitemid 41321414)
16. Mattsson J, Jansson M, Wernerson A, Hassan M,. Lung epithelial cells and type II pneumocytes of donor origin after allogeneic hematopoietic stem cell transplantation. Transplantation 2004: 78: 154-157.
17. Ringdén O, Uzunel M, Sundberg B, et al., Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon. Leukemia 2007: 21: 2271-2276. (Pubitemid 350011699)
18. Hennrick KT, Keeton AG, Nanua S, et al., Lung cells from neonates show a mesenchymal stem cell phenotype. Am J Respir Crit Care Med 2007: 175: 1158-1164. (Pubitemid 46855457)
19. Peister A, Mellad JA, Larson BL, Hall BM, Gibson LF, Prockop DJ,. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 2004: 103: 1662-1668. (Pubitemid 38268957)
20. Dobson KR, Reading L, Haberey M, Marine X, Scutt A,. Centrifugal isolation of bone marrow from bone: An improved method for the recovery and quantitation of bone marrow osteoprogenitor cells from rat tibiae and femurae. Calcif Tissue Int 1999: 65: 411-413. (Pubitemid 29514082)
21. Gnecchi M, Melo LG,. Bone marrow-derived mesenchymal stem cells: Isolation, expansion, characterization, viral transduction, and production of conditioned medium. Methods Mol Biol 2009: 482: 281-294.
22. Dominici M, Le Blanc K, Mueller I, et al., Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006: 8: 315-317. (Pubitemid 44269669)
23. Rochefort GY, Delorme B, Lopez A, et al., Multipotential mesenchymal stem cells are mobilized into peripheral blood by hypoxia. Stem Cells 2006: 24: 2202-2208. (Pubitemid 44527473)
24. Thébaud B, Ladha F, Michelakis ED, et al., Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: Evidence that angiogenesis participates in alveolarization. Circulation 2005: 112: 2477-2486. (Pubitemid 41504498)
25. Gao JZ, Dennis JE, Muzic RF, Lundberg M, Caplan AI,. The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs 2001: 169: 12-20. (Pubitemid 32437040)
26. Devine SM, Cobbs C, Jennings M, Bartholomew A, Hoffman R,. Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into non-human primates. Blood 2003: 101: 2999-3001. (Pubitemid 36857986)
27. Husain AN, Siddiqui NH, Stocker JT,. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol 1998: 29: 710-717. (Pubitemid 28322056)
28. Uccelli A, Moretta L, Pistoia V,. Immunoregulatory function of mesenchymal stem cells. Eur J Immunol 2006: 36: 2566-2573. (Pubitemid 44608440)
29. Lee RH, Pulin AA, Seo MJ, et al., Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 2009: 5: 54-63.
30. Ortiz LA, Dutreil M, Fattman C, et al., Interleukin 1 receptor antagonist mediated the anti-inflammatory and antifibrotic effects of MSCs during acute lung injury. Proc Natl Acad Sci U S A 2007: 104: 11002-11007. (Pubitemid 47175216)
31. Lee JW, Fang X, Gupta N, Serikov V, Matthay MA,. Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the perfused human lung. Proc Natl Acad Sci U S A 2009: 106: 16357-16362.
32. Krause DS, Theise ND, Collector MI, et al., Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 2001: 105: 369-377. (Pubitemid 32455343)
33. Theise ND, Henegariu O, Grove J, et al., Radiation pneumonitis in mice: A severe injury model for pneumocyte engraftment from bone marrow. Exp Hematol 2002: 30: 1333-1338. (Pubitemid 35287587)
34. Jiang Y, Jahagirdar BN, Reinhardt RL, et al., Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002: 418: 41-49. (Pubitemid 34742565)
35. Chang JC, Summer R, Sun X, Fitzsimmons K, Fine A,. Evidence that bone marrow cells do not contribute to the alveolar epithelium. Am J Respir Cell Mol Biol 2005: 33: 335-342. (Pubitemid 41416283)
36. Kotton DN, Fabian AJ, Mulligan RC,. Failure of bone marrow to reconstitute lung epithelium. Am J Respir Cell Mol Biol 2005: 33: 328-334. (Pubitemid 41416282)
37. Van Haaften T, Bryne R, Bonnet S, et al., Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats. Am J Respir Crit Care Med 2009: 180: 1131-1142.
38. Aslam M, Baveja R, Liang OD, et al., Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease. Am J Respir Crit Care Med 2009: 180: 1122-1130.
39. Ambalavanan N, Carlo WA, D'Angio CT, et al., Cytokines associated with bronchopulmonary dysplasia or death in extremely low birth weight infants. Pediatrics 2009: 123: 1132-1141.
40. Thompson A, Bhandari V,. Pulmonary biomarkers of bronchopulmonary dysplasia. Biomark Insights 2008: 3: 361-373.
41. Ajuebor MN, Das AM, Virag L, Flower RJ, Szabó C, Perretti M,. Role of resident peritoneal macrophages and mast cells in chemokine production and neutrophil migration in acute inflammation: Evidence for an inhibitory loop involving endogenous IL-10. J Immunol 1999: 162: 1685-1691. (Pubitemid 29307046)
42. Shanley TP, Vasi N, Denenberg A,. Regulation of chemokine expression by IL-10 in lung inflammation. Cytokine 2000: 12: 1054-1064. (Pubitemid 30479489)
43. Spight D, Zhao B, Haas M, Wert S, Denenberg A, Shanley TP,. Immunoregulatory effects of regulated, lung-targeted expression of IL-10 in vivo. Am J Physiol Lung Cell Mol Physiol 2005: 288: L251-L265. (Pubitemid 40105364)
44. Németh K, Leelahavanichkul A, Yuen PS, et al., Bone marrow stromal cells attenuate sepsis via prostaglandin E2-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 2009: 15: 42-49.